Cargando…
Molecular and Cellular Mechanisms of Electronegative Lipoproteins in Cardiovascular Diseases
Dysregulation of glucose and lipid metabolism increases plasma levels of lipoproteins and triglycerides, resulting in vascular endothelial damage. Remarkably, the oxidation of lipid and lipoprotein particles generates electronegative lipoproteins that mediate cellular deterioration of atherosclerosi...
Autores principales: | Ke, Liang-Yin, Law, Shi Hui, Mishra, Vineet Kumar, Parveen, Farzana, Chan, Hua-Chen, Lu, Ye-Hsu, Chu, Chih-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760527/ https://www.ncbi.nlm.nih.gov/pubmed/33260304 http://dx.doi.org/10.3390/biomedicines8120550 |
Ejemplares similares
-
Clinical Significance of Electronegative Low-Density Lipoprotein Cholesterol in Atherothrombosis
por: Chu, Chih-Sheng, et al.
Publicado: (2020) -
An Increased Plasma Level of ApoCIII-Rich Electronegative High-Density Lipoprotein May Contribute to Cognitive Impairment in Alzheimer’s Disease
por: Chan, Hua-Chen, et al.
Publicado: (2020) -
Electronegative low density lipoprotein induces renal apoptosis and fibrosis: STRA6 signaling involved
por: Chen, Chao-Hung, et al.
Publicado: (2016) -
Low-Density Lipoprotein Electronegativity Is a Novel Cardiometabolic Risk Factor
por: Hsu, Jing-Fang, et al.
Publicado: (2014) -
Electronegative low‐density lipoprotein of patients with metabolic syndrome induces pathogenesis of aorta through disruption of the stimulated by retinoic acid 6 cascade
por: Chen, Chao‐Hung, et al.
Publicado: (2019)